Download Program
Poster Number Name Organisation Paper Title
2 Colin Sutherland London School of Hygiene & Tropical Medicine A double threat to ACT efficacy in Africa: reduced susceptibility of Plasmodium falciparum to both artemisinin and lumefantrine
4 Ashley Osborne Menzies School Of Health Research A high-resolution analysis of Plasmodium falciparum population dynamics in East Africa and genomic surveillance along the Kenya-Uganda border
6 Jessica Home The University Of Melbourne A novel mechanism of clindamycin resistance in Plasmodium
8 Arnab Pain King Abdullah University of Science and Technology (KAUST) A Plasmodium-specific AP2-P regulates multiple pathogenicity factors during the IDC
10 Oliver Looker Burnet Institute A screen for identifying inhibitors of Plasmodium falciparum protein export identifies dual inhibitors of protein trafficking and parasite invasion
12 Matt Govendir EMBL Barcelona A sticky situation: the influence of microvessel mechanics on cerebral malaria pathogenesis
14 Manuel Llinás Penn State University African malaria parasites carry a C-terminal deletion in PfAP2-G that has a major impact on sexual commitment
16 Carla Proietti University Of Queensland An aberrant transcriptomic and methylation profile in individuals with sickle cell trait is associated with protection against P. falciparum malaria
18 Chen Xue Chiba University Analysis of a point mutation of cytochrome b in atovaquone-resistant malaria parasites
20 Ellen Kearney Burnet Institute Anopheles salivary antibodies as serological biomarkers of Anopheles species-specific biting exposure: A controlled human challenge study
22 Abhishek Mewara Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India Application of machine-learning (ML) based approach for detection of malaria parasite on microscopy
24 Esrah Du Harvard T. H. Chan School Of Public Health Are you sleeping? Understanding mechanisms of Plasmodium falciparum oocyst dormancy in response to stress
26 Ghizal Siddiqui Monash University Artemisinin-resistant Kelch13 mutations are associated with reduced drug activation and enhanced anti-oxidant capacity, which can be targeted to overcome resistance
28 David Khoury Kirby Institute, Unsw Assessing antimalarial drug activity in pre-clinical and early clinical trials: parasite viability versus parasite clearance
30 Luzia Bukali QIMR Berghofer Medical Research Institute Assessing the immunomodulatory potential of Ruxolitinib during controlled human malaria infection.
32 Brendan Farrell Department of Biochemistry, University Of Oxford Assessing the structure and function of vaccination-induced and naturally-acquired antibodies targeting the blood-stage vaccine candidate PfRCR
34 Maria Saeed The University Of Melbourne Association of novel potential IgG3 allotype with malaria in children from Sepik region of Papua New Guinea
36 Rubayet Elahi Johns Hopkins Bloomberg School Of Public Health BeLL the CAT: tRNA Ile-lysidine synthetase is essential for apicoplast Maintenance in Plasmodium falciparum
38 Yvonne Adams University of Copenhagen Brain Barriers and Cerebral Malaria: understanding impact of ICAM-1/EPCR dual adhesive parasites on the Choroid Plexus
40 Julianne Hamelink The Burnet Institute Can JAK1/2 blockade improve humoral immunity to malaria? Preliminary results from a phase-1b randomized placebo-controlled trial.
42 Kannan Venugopal University of Zurich CC camera footage of parasite puberty – A real time capture of sexual commitment through conversion in Plasmodium falciparum.
44 Mun Hua Tan University Of Melbourne Changing how we think about evaluating malaria interventions: making the parasite rather than the host the unit of measurement
46 Xiangning Liu Australian National University Characterisation of the novel Plasmodium falciparum heteromeric pantothenate kinase (PanK) complex
48 Emma Mao The University of Adelaide Characterising the quick-killing mechanism of action of azithromycin analogues
50 Jandeli Niemand University of Pretoria Chemical confirmation of mitochondrial pyruvate carrier complex activity in intraerythrocytic Plasmodium falciparum parasites
52 Carlo Giannangelo Monash University Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria
54 Meghan Zadow University Of Adelaide Cleaving the confusion – Reassessment of protease inhibitor activity against malaria invasion.
56 Anna Truong Duke University Covalent inhibitor reveals P. falciparum Ubc13 interactome
58 Long Huynh The University Of Melbourne Cytostome formation in artemisinin resistant Plasmodium parasites
60 Edwin Sutanto Exeins Health Initiative Deconvolving genetic complexity in Plasmodium vivax infections
62 Paolo Bareng Deakin University Defining Immune Escape Polymorphisms In Plasmodium Vivax: Insights From The Genomic Analysis Of 16 Antigen Vaccine Candidates
64 Rosy Cinzah University Of Melbourne / Burnet Institute Defining targets and mechanism of action of immunity against Plasmodium vivax malaria.
66 Cielo Pasay QIMR Berghofer Medical Research Institute Detection of P. falciparum hrp2 and hrp3 gene deletions by multiplex digital PCR
68 Alex Johnston Institute For Glycomics Development of a mixed adjuvant approach to improve the efficacy of a whole parasite blood-stage malaria vaccine candidate
70 Laura Torres Biomedical Research, Novartis Development of nanobody-based system to induce proximity between host autophagy proteins and a parasitophorous-vacuole membrane protein during malaria liver stage
72 David Jones The Francis Crick Institute Differential trafficking of P. falciparum’s exported proteins in response to febrile temperature heat stress
74 Dominic Selorm Yao Amuzu MRC Unit, The Gambia at London School of Hygiene and Tropical Medicine Distribution Of Polymorphisms In Malaria Associated Host Genes Arl15, Atp2b4, Cd40, G6pd And Inpp4b Across Selected Malaria Endemic African Populations
76 Amaya Ortega Burnet Dynamics And Longevity of IgG antibodies to P.falciparum antigens in pregnant women following infection and IPTp treatment: IMPROVE Clinical Trial.
78 Lizzie Tchongwe-Divala University of Glasgow Elucidating a putative role of PfNT1 in malaria transmission
80 Samuel Pazicky School of Biological Sciences, Nanyang Technological University Dynamics of protein complexes mapped in live malaria parasites
82 Sophia Raine Hernandez Umeå University EMAP3 is a novel protein exported to the surface of the Plasmodium berghei infected red blood cell
84 Charles Narh Deakin University Epidemiological overlaps in Malaria and COVID-19 in healthcare and community settings of Southern Ghana
86 Atefeh Fathi Obihiro University Of Agriculture And Veterinary Medicine Essential Role of Spherical Body Protein 3 on Survival and Ridge Formation of Babesia bovis
88 Lucie Paloque Cnrs Evolution of Plasmodium falciparum parasites sensitivity to artemisinin under selective pressure: a monitorable process
90 Jing Wen Ang A*STAR / NTU Examining the biological relevance of Plasmodium Interspersed Repeats (PIRs) in Plasmodium yoelii
92 Daniela Da Silva Goncalves Burnet Institute Expanding molecular detection of malaria utilising Rapid Diagnostics Tests from surveillance programs in the Greater Mekong Subregion
94 Yunyang Zhou Monash Institute Of Pharmaceutical Sciences (MIPS) Exploring the Potential of Plasmodium falciparum Exportin-1 as a Target for 2- Aminobenzimidazoles through Nuclear Fractionation Coupled Proteomics
96 Damen Dume Infinity Bio, Inc. Factors Influencing the Spread of Malaria in Cameroon: Perspective of the Local Communities.
98 Alessia Hysa Burnet Institute / The University Of Melbourne Fine specificity of RTS,S-induced antibodies in children to epitopes of the Plasmodium falciparum circumsporozoite protein and their correlation with protection.
100 Jonathan Suurbaar University of Glasgow Functional Characterization of Acetyl CoA transporter and NIMA related Kinases (NEK) in Plasmodium berghei gametocyte development
102 Jerzy Dziekan The Walter and Eliza Hall Institute of Medical Research Functional Proteomics approaches for drug-target identification and drug-mechanisms of action profiling in Plasmodium falciparum
106 Sandra Duffy Griffith University High-throughput evaluation of speed of kill and parasite stage of arrest: malaria drug discovery.
108 Nutpakal Ketprasit Department Of Biochemistry And Pharmacology, Bio21 Institute, The University Of Melbourne Hijacking tRNA charging process: a novel approach to combat malaria
110 Rafael Oliveira Charité – Universitätsmedizin Berlin Host iron environment impact on P. falciparum infection
112 Scott Chisholm University Of Cambridge hyperLOPIT spatial proteomics reveals the effect of Plasmodium infection on the host erythrocyte
114 Joseph Visone Weill Cornell Medicine Identification of a key regulatory mechanism influencing var switching and antigenic variation in Plasmodium falciparum
116 Natalie Counihan Deakin University Identification of novel Plasmodium proteins involved in parasite-host cell interactions
118 Kaitlin Pekin Burnet Institute Identifying Merozoite Surface Proteins as Targets of Protective Functional Antibody Responses against Plasmodium falciparum and P. vivax malaria
120 Jason Mcgowan Anu immune responses to Plasmodium induced cell wounding
122 Damian Oyong Burnet Institute Impact of splenic parasite reservoir on human germinal centre responses in asymptomatic Plasmodium infection.
124 Gigliola Zanghi CGIDR In vivo assessment of Plasmodium vivax Chesson liver stage infection: novel studies to assess hypnozoite formation, persistence, activation, and relapse
126 Sachie Kanatani Johns Hopkins Bloomberg School of Public Health Interrogating the Plasmodium oocyst using deep learning-based segmentation and 3D reconstruction
128 Kurt Ward University of New South Wales Investigating antimalarial resistance to proteasome inhibitors
130 Adele Lehane Australian National University Investigating Plasmodium falciparum transporters involved in drug action and resistance
132 Nicole Smith Mcfadden Lab – University Of Melbourne Investigating post-translational processing in the apicoplast to confirm mechanisms of clindamycin resistance in Plasmodium berghei
134 Kapil Pareek Institute For Microbiology, University Hospital Erlangen Investigating the effect of parasite density on parasite metabolism and epigenetic modifications
136 Robyn Mcconville The Walter And Eliza Hall Institute Investigating the role of HSP101 in Plasmodium pre-erythrocytic development
138 Katherine O’Flaherty Burnet Institute Investigation of the relationship between naturally acquired antimalarial antibodies and the duration and clearance of ultra-low density Plasmodium vivax infection
140 Dionne Argyropoulos Bio21 Institute And The Peter Doherty Institute, The University Of MelbourneDepartment of Microbiology and Immunology, B Local spatiotemporal population genetics of Plasmodium falciparum infections following the cessation of indoor residual spraying in Bongo District, Ghana
142 Kami Kim University of South Florida Machine learning analysis of parasite and host biomarkers that contribute to pediatric cerebral malaria phenotypes.
144 Françoise Benoit-vical Inserm Metabolism of Plasmodium falciparum artemisinin-resistant: a promising avenue for novel antiplasmodial drugs
146 Angela Rumaseb Menzies School Of Health Research MinION sequencing for rapid surveillance of imported Plasmodium vivax cases
148 Dawson Ling Burnet Institute MMV687794 impairs blood-stage Plasmodium falciparum invasion by perturbing lysophospholipids
150 Sachintha Wijegunasekara Burnet Institute Modular Amplicon Sequencing Analysis Platform (ASAPMod): An interactive, user-friendly modular platform for end-to-end analysis of targeted amplicon sequencing data
152 Lee Yeoh Burnet Institute Monoclonal antibodies to Plasmodium vivax AMA1 can elicit functional immune responses and reveal novel invasion interactions
154 Go Ka Diam Nanyang Technological University Multifaceted Artemisinin Mode of Actions in Plasmodium falciparum Investigated by Mass Spectrometry-Cellular Thermal Shift Assay (MS-CETSA) and Cryo-Electron Microscopy.
156 Jaison D Sa WEHI Nanobodies against malaria parasite adhesins that block invasion
158 Li-Jin Chan WEHI Nanobodies that block ancient fusogen HAP2 in malaria parasite fertilization
160 Yvonne Dube The Peter Doherty Institute Of Infection And Immunity, University Of Melbourne Non-pregnancy specific immunity: Understanding role of functional antibody features in protection from malaria in pregnant women
162 Anna Rosanas Urgell Institute of Tropical Medicine, Antwerp Novel HIVE sequencing technology makes single-cell sequencing possible for malaria field isolates
164 Chun Keung Pang The Chinese University of Hong Kong Orally-active malaria vaccine through Lactobacillus. casei – An in vitro validation
166 Omar Janha University of Glasgow PfCLK3 as putative master regulator of RNA-splicing in Plasmodium parasites.
168 Thi Kim Tuyen Nguyen Oxford University Clinical Research Unit-vietnam Pfhrp2 And Pfhrp3 Gene Deletions Among Symptomatic Plasmodium Falciparum Malaria Patients In Three Malaria Hot Spots Of Vietnam
170 Junpei Fukumoto Institute Of Tropical Medicine, Nagasaki University Pivotal role of Plasmodium falciparum lysophosphospholipid acytransferase 1 (PfLPLAT1) in cell cycle progression and cytostome internalization
172 Scott Millar University Of Glasgow Plasmodium berghei histone deacetylase 1 (HDA1) plays important, dual, sex specific roles in gametocyte maturation and viability
174 Julian Barth Justus Liebig University Giessen Plasmodium falciparum and human host chaperones, co-chaperones and their interaction as a target for drug development
176 Jesse Rop University of Cambridge (Wellcome Sanger Institute) Plasmodium falciparum relatedness and transmission in natural infections at single-cell resolution
178 Jacob Westaway Menzies School Of Health Research Population genetics analysis of Plasmodium knowlesi in Malaysia reveals complexity of human infections and differentiation of subpopulations in Borneo.
180 Audrey Sergerie Laval University Potential role of a phosphoinositide effector with a Pleckstrin Homology domain in organelle biogenesis in the malaria parasite Plasmodium falciparum
182 Dulcie Lautu-Gumal Burnet Institute Proliferation and spread of Plasmodium falciparum kelch13 C580Y mutations in parasite populations on the north coast of Papua New Guinea.
184 Salimata Kante ICER-Mali/USTTB Protective humoral response associated with P.falciparum Pf27 antigens and its ortholog P.vivax Pv27 in sera from malaria-endemic areas in Mali
186 Vrushali Khobragade Nanyang Technological University Regulation of Plasmodium falciparum gametocyte morphology
188 Lyn-marie Birkholtz University Of Pretoria Repositioning antitubercular clinical candidates as antimalarials with polypharmacology against multiple stages of Plasmodium falciparum
190 Jude Przyborski Justus-liebig University Gießen Reverse genetics reveals further proteins involved in host cell modification
192 AKACHUKWU ONWUKA University of Melbourne Role Of Igg Antibodies In Protection From Placental Malaria Birth Outcomes
194 Maria Gancheva The University Of Adelaide Screening a library of natural microbial metabolites against Plasmodium falciparum
196 Brendan Crabb Burnet Institute Sequence elements within the PEXEL motif and its downstream region modulate PTEX dependent protein export in Plasmodium falciparum.
198 Rebecca Lees Birkbeck, University of London Should I stay or should I go? Role of merozoite surface protein 1 in P. falciparum egress from erythrocytes
200 Dean Andrew QIMR Berghofer Spatial imaging and phenotypic analysis of immune cells and malaria parasites in Plasmodium infected human spleens
202 Maria Bernabeu EMBL Barcelona Stem cell-derived microvascular infection models to study malaria pathogenesis
204 Tamarah Koleala Papua New Guinea Institute Of Medical Research Strengthening vector-bone disease sentinel surveillance and use of data for decision-making in Papua New Guinea
206 Samuel Chamberlain University of Oxford Structural characterisation of RIFIN-immune receptor complexes and new insights into the regulation of innate immune signalling
208 Honghua Ding The University Of Melbourne, The Peter Doherty Institute Association of Plasmodium falciparum specific afucosylated IgG with immune protective function activation
210 Sachin Khurana Walter And Eliza Hall Institute, Melbourne, Australia Targeted protein degradation in the human malaria parasite
212 Josephine Boentoro Nanyang Technological University Temporal dose-response transcriptional profiling of drug-treated Plasmodium falciparum for elucidation of antimalarial mode of action
214 Katherine Andrews Griffith University The activity of slow-action antiplasmodial 1,3,4-oxadiazoles is associated with in vitro resistance to P. falciparum palmitoyltransferase DHHC7
216 Paul Gilson Burnet Institute The Dual Action of Human Antibodies Specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking Invasion and Inactivating Extracellular Merozoites.
218 Célia Garcia Faculdade de Ciências Farmacêuticas da Universidade de São Paulo – FCF/USP The genetically encoded calcium indicator GCaMP3 reveals spontaneous calcium oscillations at asexual stages of the human malaria parasite Plasmodium falciparum
220 Pailene Lim Walter And Eliza Hall Institute Of Medical Research The molecular definition of potent Plasmodium falciparum invasion inhibitory epitopes on PTRAMP-CSS
222 Mohini Anjna Shibu The University Of Melbourne The PHIST protein PF3D7_0532300 interacts with the RBC membrane skeleton and modulates knob formation
224 Richard Bartfai Radboud University The protein landscape of the chromatin states in P. falciparum parasites
226 Sophia DonVito London School of Hygiene and Tropical Medicine The role of reticulocyte binding-like (RBL) and Duffy binding-like (DBL) proteins in host cell tropism during erythrocyte invasion.
228 Tomoko Ishino Tokyo Medical And Dental University The roles of rhoptry bulb proteins in Plasmodium sporozoites
230 Nicolas Aranciaga Nanyang Technological University, Singapore Plasmodium knowlesi’s transcriptomic-mediated adaptation to the human host
232 Melissa Hart Royal Veterinary College To process or not to process: the role of the PfRh5 pro-domain in red blood cell invasion.
234 Krishanpal Karmodiya Indian Institute of Science Education & Research, Pune. Transcriptional heterogeneity and stress responses in artemisinin resistance
236 Sade Pratt London school of hygiene and tropical medicine Transmissibility to mosquitoes of African Plasmodium falciparum carrying emerging drug resistance-associated gene variants
238 Melissa Penny Telethon Kids Institute Understanding risk of malaria vaccine genotype replacement and spread
242 Ashton Kelly The Institute for Molecular Bioscience Unravelling the molecular basis of immune heterogeneity to Plasmodium falciparum infection using high-dimensional immune profiling
244 Kazuhide Yahata Pros, Ehime University Unveiling Gliding Motility in Plasmodium Merozoites
246 Stephanie Routley Burnet Institute Using ultra-sensitive qPCR to detect low-density Plasmodium spp. infections in Papua New Guinea
248 Joana Ferreira Costa The University Of Melbourne When SWEETs turn sour: a hypothesis for the origin(s) of parasitism in Apicomplexa
250 Niall Geoghegan WEHI 4D Lattice Light Sheet Microscopy of cytoskeletal breakdown, tight junction formation and calcium signalling during P.Falciparum invasion of erythrocytes
252 Jasmin Akter ICDDR,B, Bangladesh and Deakin University Establishing genomic surveillance for early warning of antimalarial drug resistance in Bangladesh
254 Benjamin Seager Walter And Eliza Hall Institute A conserved molecular mechanism of erythrocyte invasion by malaria parasites
256 Mary-Louise Wilde University Of Melbourne Development of gene drives to directly target malaria parasites
Poster Number Name Organisation Paper Title
3 Albina Waithaka Umea University A genetic screen for factors involved in translation de-repression of Plasmodium berghei maternal mRNAs.
5 Eleanor Silvester University Of Cambridge A novel combinatorial genetic approach to explore interdependencies between Plasmodium falciparum invasion ligands
7 Sumit Rathore All India Institute of Medical Sciences, New Delhi A Plasmodium vivax merozoite protein PvTRAg36.6 of PvFam-a family interacts with Transferrin receptor (CD71) on human reticulocytes for invasion process
9 Alyssa Barry Deakin University A population genomic model for measuring antigenic escape and predicting serotypes for malaria vaccine candidates
11 Grace Vick University Of Georgia A SNARE-like Plasmodium rhoptry neck protein is required for merozoite invasion.
13 Xuexin Xia The University Of Melbourne Adjustment of the sex ratio of malaria parasites and its influencing factors
15 Jennifer Le Monash University Amino alcohol partner drugs antagonise artemisinin activity and potentiate resistance in a ring stage survival assay
17 Emma McHugh University of Melbourne An essential dynamin-like protein at the cytostome of Plasmodium falciparum
19 Ryuta Ishii Institute of tropical medicine, Nagasaki university Analysis of liquid-liquid phase separation in Plasmodium falciparum
21 Elizabeth Villasis Universidad Peruana Cayetano Heredia Antibody parameters of P .vivax asymptomatic infections in the Peruvian Amazon.
23 Dionne Argyropoulos Bio21 Institute And The Peter Doherty Institute, The University Of MelbourneDepartment of Microbiology and Immunology, B Are semi-immune individuals with asymptomatic Plasmodium falciparum infections carriers of drug resistant parasites in a high-transmission setting in northern Ghana?
25 Marcus Lee University Of Dundee AReBar: an Antimalarial Resistome Barcode assay for target deconvolution
27 Madeline Dans Wehi Aryl acetamide compound MMV006833 inhibits a phospholipid transfer protein important for the development of newly invaded Plasmodium falciparum merozoites
29 Bhagyashree Deshmukh Indian Institute of Science Education & Research, Pune, India Assessing the efficiency of multi-protein chimeric antigens targeting the blood stage of Plasmodium falciparum using microfluidic systems
31 Jessica Loughland Qimr-berghofer Assessing the potential of Plasmodium falciparum to induce innate cell memory.
33 Victoria Mendiola University Of Georgia Assessing viability of Plasmodium falciparum ring stages after exposure to Artemisinin
35 Gillian Muchaamba Institute Of Parasitology, Vetsuisse Faculty, University Of Zürich Avian malaria: an emerging threat to captive and wild birds
37 Melanie Dietrich WEHI Blocking interactions of Plasmodium falciparum 6-cysteine proteins using inhibitory nanobodies
39 Thomas Lavstsen University of Copenhagen Broadly reactive human monoclonal antibodies against severe malaria-associated Plasmodium falciparum erythrocyte membrane protein 1
41 Sarah Farrell The University Of Melbourne Can we target the mosquito stages of Plasmodium with ‘drugs’ to reduce transmission?
43 Xiaoxia Lin Chiba University Challenges in elucidation of mitochondrial ribosome structure of the malaria parasite
45 Rebecca Edgar University Of Dundee Characterisation of a novel dual aminopeptidase inhibitor that shows cross-species reactivity and excellent potential as a novel partner drug
47 Cas Boshoven Radboudumc Characterising the binding and resistance mechanism of a novel class of potent antimalarials targeting a mitochondrial carrier protein.
49 Dina Coertzen University Of Pretoria Characterizing differential oxidative stress responses in P. falciparum asexual and gametocyte stages
51 Wenyin Su Walter and Eliza Hall Institute of Medical Research Chemical-genetics using substrate peptidomimetics defines their on-target activity for the essential malaria aspartyl protease, plasmepsin V
53 Hannah Kelly Australian National University Circumsporozoite-protein specific CD4+ T cells form resident memory population in the liver and may kill liver stage parasites in vivo
55 Annie Roys Mips Combination of redox modifiers with artemisinin results in increased parasite susceptibility to artemisinins
57 Julia Zerebinski Karolinska Institute Cross reactivity of antibody responses to Plasmodium falciparum vaccine candidate antigen MSP2 during natural infection
59 Jo-anne Chan Burnet Institute Deciphering the role of functional antibody responses in transmission-blocking immunity to P. falciparum
61 Timothy Ho Burnet Insitute/Monash University Defining functional antibody epitopes of P. falciparum merozoite surface proteins to inform next-generation vaccine design
65 Ganesh Ram Visweswaran Seattle Childrens Research Institute Design and development of a multistage malaria vaccine
67 Brad Sleebs Walter And Eliza Hall Institute Development and characterisation of a novel antimalarial chemotype that targets PfATP4
71 Vishnu Teja Nallapati Kasturba Medical College, Manipal, Manipal Academy Of Higher Education, Manipal Diagnostic Performance of hemozoin-based assay versus Rapid Diagnostic Tests for Malaria detection in the southwestern region of India
73 Zuleima Pava QIMR Berghofer Dissecting malaria driven transcriptional changes longitudinally in patient single cell RNA seq data sets.
75 Paola Favuzza WEHI Dual Plasmepsin Inhibitors: 3 stage malaria inhibitory potency and robust P. falciparum resistance profile
77 Iset Vera University of South Florida Elevated thrombogenic autoantibodies in the pathogenesis of pediatric cerebral malaria.
79 Bárbara Karina de Menezes Dias University of São Paulo Elucidating the role of PfeIK1 in Plasmodium falciparum melatonin mediated synchronization
81 Himashree Choudhury Jawaharlal Nehru University Elucidation of novel signaling pathways involved in egress of malaria parasite Plasmodium falciparum using genome editing tool
83 Franca Azzato Victorian Infectious Disease Reference Laboratory Enhancing Plasmodium falciparum drug resistance surveillance with capture-based sequencing
85 Jean-Michel Augereau CNRS Epidrugs for elimination of Plasmodium falciparum artemisinin-resistant and quiescent parasites, a promising therapeutic avenue.
87 Paul, Pickering, Simone Dowd ADFMIDI Evaluating the performance of malaria LAMP in field setting for ADF-PNGDF malaria surveillance in PNG
89 Sonalika Kar ICMR-National Institute of Malaria Research Evolutionary inferences of P. vivax Duffy Binding Protein II (Pvdbp-II): the Indian scenario
91 Barbara Stokes University of Glasgow Examining the role of host cell maturation in malaria parasite development in the hematopoietic niche
93 Colin Sutherland London School of Hygiene & Tropical Medicine Experimental studies of drug, vaccine and gene variant impact on Plasmodium spp. infections in mosquitoes
95 Amaya Ortega Burnet Extracellular Vesicles released by Plasmodium falciparum-infected RBC induce pro-inflammatory mediators from leucocytes
97 Elizabeth Aitken Peter Doherty Institute, University Of Melbourne FcγRIIIA binding antibody on the surface of Plasmodium falciparum infected red blood cells is associated with protection from disease
99 Katrina Larcher Wehi Functional characterisation of the GAPM proteins in asexual and sexual stage development.
101 Joshua Waterhouse Burnet Institute Functional IgG to Merozoite Antigens AMA1 and MSP2 are associated with Protection from Malaria in a Longitudinal Malaria Cohort
103 Parsakorn Tapaopong Mahidol Vivax Research Unit, Faculty Of Tropical Medicine, Mahidol University Genetic diversity and molecular evolution of Plasmodium vivax Duffy Binding Protein and Merozoite Surface Protein-1 in northwestern Thailand
105 Roland Cooper Dominican University Of California High-level resistance to antimalarial acridones conferred by sequential mutations in the P. falciparum cytochrome B and dihydroorate dehydrogenase genes.
107 Thorey Kolbrun Jonsdottir Umeå University, The Laboratory for Molecular Infection Medicine Sweden (MIMS) High-throughput gene editing system enables CRISPR screens in Plasmodium berghei
109 Noella Efange University of Buea Hit Discovery and Optimisation of Spirofused Tetrahydroisoquinoline-Oxindole Hybrids as a new class of Multitargeted and Multistage Active Antimalarial Compounds
111 Elena Lantero Escolar Walter and Eliza Hall Institute of Medical Research How to catch a parasite red-handed? Looking for Plasmodium falciparum exported proteins in the infected hepatocyte
113 Alicia Wagner Northeastern University Identification and structural optimization of a core-independent carboxamide chemotype as novel P. falciparum inhibitors
115 Martina Paoletta Umeå University Identification of novel Plasmodium exported proteins and their role in infection and disease
117 Herbert Opi Burnet Institute Identification of targets of protective antibody responses against Plasmodium vivax malaria using a multifunctional antibody profiling approach
119 Matthew Gibbins University Of Glasgow Imaging Plasmodium berghei gametocyte behaviour in the skin of mice
121 Richard Thomson-luque University Of Heidelberg / Sumaya-biotech Immunization with the Plasmodium falciparum full-length MSP1 malaria vaccine candidate SumayaVac-1 in naïve population
123 Konstantinos Kousis The Francis Crick Institute In need of calcium: the role of Plasmodium falciparum ATP6 in asexual blood stage development
125 Stephanie Studniberg Monash Biomedicine Discovery Institute Integrated systems immunology approach identifies persistent blood monocyte dysfunction induced by both symptomatic and asymptomatic Plasmodium vivax malaria
127 John McCauley Msd Invention of MK-7602: An antimalarial drug discovery academic/industrial collaboration
129 Leonhard Arinanto The University Of Melbourne Investigating Cytosolically Exposed Rhoptry-interacting Proteins (C-RIPs) of Plasmodium falciparum During Sporozoites Traversal and Invasion.
131 Morven Law London School Of Hygiene And Tropical Medicine Investigating post-translational modifications on Plasmodium knowlesi erythrocyte binding proteins during invasion
133 Erick T. Tjhin The Australian National University Investigating the antiplasmodial activity of spinosyns against Plasmodium falciparum
135 Bruce Munro Jcsmr – Anu Investigating the gametocytocidal activity of an anti-plasmodial peptide derived from a human host defence protein
137 Joyanta Modak Deakin University Investigating the role of TRX2 in trafficking malaria virulence proteins
139 Michael Filarsky Eberhard Karls University Tuebingen Lnced to commitment – The role of long non-coding RNAs in regulating the onset of sexual commitment in Plasmodium falciparum
141 Cecilia Rios Teran The University Of Melbourne Longitudinal analysis of the prevalence of minor Plasmodium spp. infecting humans through sequential IRS and SMC interventions in northern Ghana
143 Sannia City Wehi, Peter Doherty Institute, University Of Melbourne Mapping The Landscape of Sex Determination in P. Falciparum
145 Geoff Birrell Australian Defence Force Malaria And Infectious Disease Institute Metabolism of Tafenoquine and Tafenoquine Drug Combinations In Vitro
147 Julie Verhoef Radboudumc Mitochondrial division in human malaria parasites
149 Benjamin Camm University Of Melbourne Modelling a gene drive in Plasmodium
151 Jaishree Tripathi National University of Singapore Molecular Characterization of Dihydroartemisinin Induced Dormant Persistor Stage in Plasmodium falciparum
153 Lauren Holz The University Of Melbourne mRNA vaccine against malaria tailored for liver-resident memory T cells
155 Darren Creek Monash University Multi-omics analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates AP2-12-dependent multi-gene family expression
157 Frankie Lyons WEHI Nanobodies targeting malaria transmission-blocking candidate
159 Patrick K. Tumwebaze Griffith University, Nathan Campus,Brisbane, Au New insights on the mode of action of the malaria drug proguanil
161 Giulia Pianta London School of Hygiene and Tropical Medicine Novel approach for rapid diagnostic test standards for non-falciparum malaria using P. knowlesi orthologue replacement
163 Paula Gomez Gonzalez London School Of Hygiene & Tropical Medicine Optimisation of inhibitors against the Plasmodium falciparum cyclic nucleotide-dependent phosphodiesterases
165 Anna Rosanas Urgell Institute of Tropical Medicine, Antwerp P. vivax genomics in South-America: a new reference genome (PvPAM) and population genetic analysis.
167 Brian Omondi University Of Edinburgh PfEMP1 IgM-binding phenotype greatly predates the origin of Plasmodium falciparum
169 Gonzalo Acevedo University Of California Pre-erythrocytic immunity beyond the sporozoite: CD4+ T cell responses against liver stage P. falciparum antigens in Ugandan children
171 Mathieu Gendrot Nanyang Technological University Plasmodium falciparum plasmepsin III long non-coding RNA implication in piperaquine resistance.
173 Hardik Patel Seattle Children’s Research Institute Plasmodium blood stage infection induced host cytokine responses suppress liver stage infection
175 Reena Mukhiya QIMR Berghofer Plasmodium falciparum induces enhanced and sustained cytokine responses in innate cells following secondary infection
177 Kirsty McCann Deakin University Population genetic signatures of Plasmodium falciparum transmission decline and rebound in a hyperendemic area of Papua New Guinea
179 Annie-Peiyuan Luo Monash University Potent and irresistible bis-1,2,4-triazines likely target the parasite nucleus
181 Jye Travis Qimr Berghofer Medical Research Institute Preliminary Elucidation of the Mechanism of Action of Tafenoquine on blood stages of Plasmodium falciparum, in vitro.
183 Linda Reiling Burnet Institute Protective associations for combinations of antibody responses inform multi-stage vaccine design
185 Eric Springer Justus Liebig University Giessen Real-time measurement of ATP – drug response in Plasmodium falciparum using genetically encoded fluorescent probes
187 Katie Hughes University Of Glasgow Regulatory protein complex dynamics during Plasmodium berghei gametocytogenesis
189 Debopam Chakrabarti Burnett School Of Biomedical Sciences, University Of Central Florida Repurposing YLIU-06-026-1, a type II human kinase inhibitor, identifies resistance-refractory prophylactic and therapeutic antimalarial
191 Naoaki Shinzawa Tokyo Medical and Dental Unviersity Rhoptry neck protein 4 is essential for merozoite invasion in Plasmodium falciparum
193 Bridget Barber Qimr Berghofer Medical Research Institute Ruxolitinib adjunctive treatment to reduce inflammatory responses in malaria: a randomised placebo controlled trial in volunteers infected with P. falciparum
195 Wisam Dawood Griffith Institute For Drug Discovery Screening virtual HDAC inhibitor libraries using QSAR in silico prediction models as a drug discovery tool for malaria
197 Caroline Duncombe University of Washington Sex hormones, CD8+ T cells, and the liver: how the endocrine-immune interface alters malaria liver-stage vaccine outcomes.
199 Francesca Florini Weill Cornell Medicine Single-cell transcriptomics reveals surprising heterogeneity in var gene expression
201 Leon Hugo QIMR Berghofer Medical Research Institute Spinosad as an endectocide for the control of Anopheles vectors of malaria
203 Michal Kucharski Nanyang Technological University / University Of Amsterdam STR polymorphism in the promoter region of cyclophilin 19B drives its transcriptional upregulation contributing to drug resistance in Plasmodium falciparum
205 Benedict Davies The Francis Crick Institute Structural and functional analysis of the malarial egress protein MSA180
207 Finn O’Donoghue Rmit Structural Phylogeny of Protein Kinases in Plasmodium falciparum: A Method for Inferring Function through Predicted Structure Comparison
209 Mariana Kleinecke Menzies School Of Health Research Targeted next generation sequencing assays to analyse Plasmodium vivax relatedness
211 Niniola Olaniyan University Of Glasgow Targeting protein kinase PfCLK1 inhibits schizont development in asexual blood stage.
213 Hayley Bullen Burnet Institute The 2-Anilino 4-Amino substituted quinazolines are irresistible and promiscuous
215 Tonny Jimmy Owalla Department of Global Health, University of Washington The daily natural history of asymptomatic Plasmodium infections in adults and older children in Katakwi, Uganda: a longitudinal cohort study
217 Jeremy Goodwin-Gower QIMR Berghofer The dynamics of parasite growth in P. falciparum and P. knowlesi co-cultures.
219 Zahra Razook Deakin University The Impact of Seasonal Malaria Chemoprevention (SMC) on P. falciparum Population diversity
221 Kioko Mwikali KEMRI-Wellcome Trust Research Programme The mRNA content of peripheral blood extracellular vesicles provides a window into cerebral malaria disease progression
223 Imam Fathoni The Australian National University The Plasmodium thiamine pyrophosphokinase activates an antiplasmodial thiamine analogue and is essential for sporozoite formation.
225 Sandra Bennink Cellular And Applied Infection Biology, RWTH Aachen University, Germany The role of putative mTORC-related kinases in translational regulation during Plasmodium falciparum transmission
227 Lara Bardtke Charité Universitätsmedizin Berlin The role of the innate immune system in semi-immunity to malaria
229 Xiangning Liu Australian National University The second enzyme in the CoA biosynthesis pathway is a novel hetero-tetrameric complex and the target of antiplasmodial pantothenate analogues
231 Katherine Andrews Griffith University Thymidine kinase-independent click chemistry DNADetect™ probes for assessment of DNA proliferation in malaria parasites
233 Amin Abbasi JLU Trafficking and sorting of proteins to the parasitophorous vacuolar membrane of P.falciparum: PfEXP1 as a model
235 Eva Stadler Kirby Institute, Unsw Sydney Translation of the Resistance Risk for the Antimalarial Drug Cabamiquine across Infection Models
237 Katelyn Stanhope Burnet Institute Transmission dynamics and population structure of P. falciparum and P. vivax in Mondulkiri Province, Cambodia
239 Mitchell Trickey Deakin University Understanding the role of rodent malaria clag genes in new permeation pathway formation
241 William Muasya University Of Glasgow Unravelling the Mechanisms of Blood-Brain Barrier Breakdown in Cerebral Malaria: Insights into Plasmodium Parasite Components
243 Luis Tavernelli University Of Glasgow Unravelling the role of PHISTc proteins in the delivery of malaria parasite antigen to the infected red blood cell surface
245 Nina Sophie Kuester Jlu University Of Giessen Using new genetic tools to elucidate the importance of exported proteins in the intra-erythrocytic survival and pathogenesis of Plasmodium falciparum
247 Melanie Lam Biomedical Research, Novartis Utilizing HaloTag Technology to Study Host-driven Targeted Degradation of Liver Stage Malaria Proteins
249 Eva Hesping Walter And Eliza Research Institute Whole-genome CRISPR/Cas9 screen to identify host factors involved in Plasmodium falciparum liver infection
251 Prasun Kundu Cambridge Institute for Medical Research Systematic reverse vaccinology screening for novel Plasmodium vivax blood-stage vaccine antigens
253 Ashley Osborne Menzies School Of Health Research Genomic epidemiology of Plasmodium vivax in the Indonesian archipelago
255 Scott Millar University Of Glasgow Unlocking Gametocyte Production: Investigating the role of ap2-g4 in P. knowlesi gametocytogenesis